FridayAug 27, 2021 10:45 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Presents CBN-Based Treatment for Glaucoma at H.C. Wainwright Ophthalmology Virtual Conference

The presentation highlighted the company’s INM-088 cannabinol topical eye drop to treat glaucoma InMed’s IntegraSyn is being used to help the company develop synthetic bioidentical rare cannabinoids in the lab, as most are only found in trace amounts in cannabis plants In addition to INM-088 for glaucoma, the company is currently working on CBN-based INM-755 to treat a rare genetic skin disorder called epidermolysis bullosa and is awaiting the answer to Phase II trial applications in various countries Dedicated to delivering new therapeutic alternatives as a treatment for conditions with a high unmet medical need, InMed Pharmaceuticals (NASDAQ: INM) is…

Continue Reading

FridayAug 27, 2021 10:17 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Set to Announce Q2 2021 Results on August 30, 2021

Red White & Bloom Brands Inc. is set to release its Q2 2021 financial results on Monday, August 30, 2021 The announcement will also be followed by an update on the company’s asset purchases, accompanying notes along with management discussion and analysis Q1 2021 saw outstanding performance for the company, with the CEO announcing intentions to finalize its revised asset purchase of the Michigan investee The August 30 announcement will give an update to this and more investment decisions for Q2 2021 On July 27, 2021, Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) announced its 2021 1st quarter…

Continue Reading

WednesdayAug 25, 2021 11:08 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Pursues Commercial Production of Rare Cannabinoids at Pharmaceutical Levels

Canadian clinical-stage drug development company InMed Pharmaceuticals is working to achieve pharmaceutical approval of rare cannabinoids InMed Pharmaceutical has developed a trademarked platform called IntegraSyn that extracts five times the normally expected yields of cannabinoids from its plant sources IntegraSyn’s ability to increase yields may ultimately help InMed to achieve a profitable means of producing cannabinol (“CBN”) and other lesser-known cannabinoids at commercial scales To date, GW Pharma’s Epidiolex is the only cannabis-derived product to achieve FDA approval as a pharmaceutical, and the company’s multi-million-dollar revenues demonstrate the potential returns a pharmaceutical-level drug can achieve British Columbia, Canada-based InMed Pharmaceuticals…

Continue Reading

WednesdayAug 25, 2021 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Completes Acquisition of Apopka Cultivation Facility Further Expanding Florida Footprint

Red White & Bloom Inc. recently completed the acquisition of an operational 45,000 square-foot greenhouse situated on 4.7 acres of land in Apopka, Florida The acquisition comes less than four months after the company closed the purchase of a property in Sanderson, Florida RWB is intent on expanding its cultivation footprint in Florida as it also seeks to grow the number of retail stores in the state The Apopka facility will add near term cultivation capacity as RWB waits for the Sanderson facility to become operational A little less than four months after completing the acquisition of a property in…

Continue Reading

TuesdayAug 24, 2021 10:40 am

Podcast Notes Blood Pressure Drug Delivery Trial Successes of Innovative Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology

Lexaria Bioscience is a drug delivery technology innovator whose flagship technology, DehydraTECH(TM), provides a means of enhancing substances’ delivery time to increase their effectiveness without adverse effects  A new podcast by NetworkNewsAudio highlights DehydraTECH’s successes in trials that measure blood pressure reduction using DehydraTECH-enhanced CBD in comparison with generic controls The DehydraTECH technology is also being analyzed for effectiveness in combatting inflammatory conditions, viral illnesses and alternatives to the lung-harming effects of smoking  The company’s most recent filing with the SEC notes that its revenues more than doubled between May 2020 and May 2021, driven largely by product sales and…

Continue Reading

MondayAug 23, 2021 11:14 am

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Chair, the Shaq Invest $2M-Plus in Private Placement

“I’m looking forward to being a key player in [The Alkaline Water Company’s] continued success,” says O’Neal WTER’s Alkaline88(R) continues to be one of the most prominent growing premium functional waters in the category Investors believe that Alkaline88 is becoming a household name for premium waters and a go-to brand across America After initially joining The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) as an equity partner, board member and marquee brand ambassador for Alkaline88(R), basketball Hall of Famer and entertainment icon Shaquille O’Neal has invested an additional of $1.05 million in the alkaline water company. O’Neal and WTER chairman Aaron…

Continue Reading

FridayAug 20, 2021 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Spreads Word About its Cannabis Operations, Announces LOI to Acquire Luxury Accessories Company Vessel Brand

Flora Growth Corp. is a global cannabis production and distribution company that has created a premium house of brands which supplying its cannabis products for cosmetics, pharmaceuticals, natural wellness, hemp textiles, and food and beverages, with high-quality product at below-standard costs Flora Growth’s primary regulatory licensed operations are in Colombia, where the country’s government recently pursued a new openness in cannabis exports and domestic regulation by lifting bans on the sale and export of dried flower and cannabinoid ingestible products, permitting the sale of custom formulas for medical cannabis, and loosened marketing restrictions Flora Growth has been actively involved in…

Continue Reading

ThursdayAug 19, 2021 12:34 pm

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Inks New Distribution Agreement in Continued Growth, Success

Company signed agreement with Premier Distribution Services to distribute entire Alkaline88(R) bottled water line PDS network includes more than 800 gyms, sports nutrition stores, personal training studios and smoothie bars “Great partnership for both parties,” says WTER CEO The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) continues its pattern of steady success with its most recent distribution announcement: the company has signed an agreement with Premier Distribution Services (“PDS”) to distribute WTER’s entire Alkaline88(R) bottled water line to more than 800 gyms, sports nutrition stores, personal training studios and smoothie bars (https://cnw.fm/74bCj). The company, now sitting atop the list of the…

Continue Reading

WednesdayAug 18, 2021 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented Technology Increasing Effectiveness and Potentially Lowering Healthcare Costs

Company’s patented DehydraTECH(TM) technology is showing the potential of reducing healthcare costs by improving oral medication administration – using capsule and pill form over injection administration Lexaria’s offering could potentially offer accelerated regulatory filing with the FDA and other regulators around the world The company sub-licenses its DehydraTECH technology for the delivery of fat-soluble active molecules and drugs while also operating four subsidiary companies  Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, recently announced results from an anti-viral drug molecular characterization study performed by the National Research Council (“NRC”). Results confirmed that the drugs tested remained stable and…

Continue Reading

MondayAug 16, 2021 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Marks Huge Milestone With The Fulfilment of Its Initial Purchase Order Valued at US$1.1m; Set to Hold First Half 2021 Earnings Call on August 19

Kasa, Flora’s food and beverage division, announced that it had completed its first purchase order valued at approximately US$1.1m This fulfillment is in line with the sales agreement with Tropi, the largest distributor in Colombia, that dates back to July 2021 and is set to last for a year This initial sale demonstrated the company’s ability to follow through with its commitments Flora is also set to hold its earnings call for the first half of the 2021 fiscal year The virtual event is scheduled for Thursday, August 19, 2021, at 4:30 p.m. E.T. Back in July 2021, Flora Growth…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977